ADHD Trial, Recruiting (NCT06974136)

ADHD Trial, Recruiting NCT06974136 Sponsor: The National Brain Mapping Laboratory (NBML) Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT06974136 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You or your child has been diagnosed with ADHD by a licensed psychiatrist, confirmed with a behavioral checklist
The child is between 7 and 18 years old
Parents or guardians are willing and able to sign a written consent form on behalf of their child

Who may not be able to join:

The child has been diagnosed with another neurodevelopmental condition alongside ADHD (such as autism spectrum disorder — confirm with trial site)
The child has been diagnosed with another neurological condition alongside ADHD (confirm with trial site)
The child has had brain surgery in the past
The child has any magnetic metal in their head (for example, from a previous injury or surgery)
The child has any implanted medical device in their head or neck (such as a cochlear implant — confirm with trial site)
The child has epilepsy that is not well controlled and has had seizures within the last year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 017642062686

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06974136

Sponsor: The National Brain Mapping Laboratory (NBML)

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: 017642062686

More information: https://clinicaltrials.gov/study/NCT06974136

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You or your child has been diagnosed with ADHD by a licensed psychiatrist, confirmed with a behavioral checklist
The child is between 7 and 18 years old
Parents or guardians are willing and able to sign a written consent form on behalf of their child

Who may not be able to join:

The child has been diagnosed with another neurodevelopmental condition alongside ADHD (such as autism spectrum disorder — confirm with trial site)
The child has been diagnosed with another neurological condition alongside ADHD (confirm with trial site)
The child has had brain surgery in the past
The child has any magnetic metal in their head (for example, from a previous injury or surgery)
The child has any implanted medical device in their head or neck (such as a cochlear implant — confirm with trial site)
The child has epilepsy that is not well controlled and has had seizures within the last year

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The National Brain Mapping Laboratory (NBML)

Registry

ClinicalTrials.gov

Start date

30 March 2025

Est. completion

1 March 2026

Where this trial is recruiting

Iran

Primary endpoints

ADHD symptoms- Clinical rating scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov